View Clinical Trial (Medical Research Study)
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation - NCT01001091-76134(Clinical Trial 379125)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Fort Worth |
|
State:
|
|
TX |
| Zip Code: |
|
76134 |
| Conditions: |
|
Allergic Conjunctivitis Associated Inflammation |
| Purpose: |
|
The purpose of this study is to assess the safety and efficacy of AL-38583 in the treatment
of the signs of inflammation associated with allergic conjunctivitis.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Presence of signs and symptoms of ocular inflammation in both eyes.
- Have a positive CAC response at Visit 1.
- Able to avoid the use of disallowed medications as well as contact lens wear for the
specified period prior to Visit 1, and for the duration of the study.
Exclusion Criteria:
- Have known history or presence of persistent dry eye syndrome.
- Presence of any ophthalmic abnormality that may affect the study outcomes.
- Have a history of moderate to severe allergic asthma reaction to mountain cedar or
the perennial allergens used in the study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|